BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1642400)

  • 1. Psychosocial aspects of melanoma.
    Gibertini M; Reintgen DS; Baile WF
    Ann Plast Surg; 1992 Jan; 28(1):17-21. PubMed ID: 1642400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological characteristics of early-stage melanoma patients: a cross-sectional study on 204 patients.
    Tesio V; Ribero S; Castelli L; Bassino S; Leombruni P; Caliendo V; Grassi M; Lauro D; Macripò G; Torta RGV
    Melanoma Res; 2017 Jun; 27(3):277-280. PubMed ID: 28207426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline psychosocial predictors of survival in localized melanoma.
    Lehto US; Ojanen M; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
    J Psychosom Res; 2007 Jul; 63(1):9-15. PubMed ID: 17586333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illness-related distress in women with clinically localized cutaneous melanoma.
    Atkinson TM; Noce NS; Hay J; Rafferty BT; Brady MS
    Ann Surg Oncol; 2013 Feb; 20(2):675-9. PubMed ID: 22965568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coping strategies in melanoma patients.
    Trapp M; Trapp EM; Richtig E; Egger JW; Zampetti A; Sampogna F; Rohrer PM; Komericki P; Strimitzer T; Linder MD
    Acta Derm Venereol; 2012 Nov; 92(6):598-602. PubMed ID: 22772950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later.
    Fawzy FI; Fawzy NW; Hyun CS; Elashoff R; Guthrie D; Fahey JL; Morton DL
    Arch Gen Psychiatry; 1993 Sep; 50(9):681-9. PubMed ID: 8357293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients.
    Lehto US; Ojanen M; Kellokumpu-Lehtinen P
    Ann Oncol; 2005 May; 16(5):805-16. PubMed ID: 15817599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and prognosis of local recurrence in malignant melanoma of the skin.
    Cruse CW; Wells KE; Schroer KR; Reintgen DS
    Ann Plast Surg; 1992 Jan; 28(1):26-8. PubMed ID: 1642402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response.
    Temoshok L
    Soc Sci Med; 1985; 20(8):833-40. PubMed ID: 4001992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for supportive counselling--the professionals' versus the patients' perspective. A survey in a representative sample of 236 melanoma patients.
    Söllner W; Zingg-Schir M; Rumpold G; Mairinger G; Fritsch P
    Psychother Psychosom; 1998; 67(2):94-104. PubMed ID: 9556201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer prognosis, psychosocial stress and attitude of melanoma patients to supportive psychotherapy].
    Söllner W; Mairinger G; Zingg-Schir M; Fritsch P
    Hautarzt; 1996 Mar; 47(3):200-5. PubMed ID: 8647703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial.
    Russell L; Ugalde A; Milne D; Krishnasamy M; O Seung Chul E; Austin DW; Chambers R; Orellana L; Livingston PM
    Trials; 2018 Apr; 19(1):223. PubMed ID: 29653555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Support and control of psychological stress as experienced by cancer patient].
    Lehto-Järnstedt US; Kellokumpu-Lehtinen P; Ojanen M
    Duodecim; 2002; 118(14):1457-65. PubMed ID: 12271602
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Stress Coping Strategies with Immunological Parameters in Melanoma Patients.
    Trapp EM; Trapp M; Avian A; Rohrer PM; Weissenböck T; Kapfhammer HP; Demel U; Linder MD; Kresse A; Richtig E
    Acta Derm Venereol; 2016 Aug; 96(217):74-7. PubMed ID: 27284002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial characteristics of individuals with non-stage IV melanoma.
    Trask PC; Paterson AG; Hayasaka S; Dunn RL; Riba M; Johnson T
    J Clin Oncol; 2001 Jun; 19(11):2844-50. PubMed ID: 11387356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients.
    Kneier AW; Temoshok L
    J Psychosom Res; 1984; 28(2):145-55. PubMed ID: 6737328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological factors in the prognosis of malignant melanoma: a prospective study.
    Rogentine GN; van Kammen DP; Fox BH; Docherty JP; Rosenblatt JE; Boyd SC; Bunney WE
    Psychosom Med; 1979 Dec; 41(8):647-55. PubMed ID: 545425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma.
    Temoshok L; Heller BW; Sagebiel RW; Blois MS; Sweet DM; DiClemente RJ; Gold ML
    J Psychosom Res; 1985; 29(2):139-53. PubMed ID: 4009515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stressful life events and the occurrence of skin cancer.
    Shidlo N; Lazarov A; Benyamini Y
    Psychooncology; 2024 May; 33(5):e6343. PubMed ID: 38697780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.